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Abstract 
 
Stem cells are undifferentiated cells capable of both self-renewal and 
multi-lineage differentiation. There are two types of stem cells: pluripotent stem cells 
(PSCs) and adult stem cells. PSCs, such as embryonic stem cells (ESCs) and induced 
pluripotent stem cells (iPSCs), can generate any cell types of the body. In contrast, adult 
stem cells have restricted potential to differentiate into certain organ or tissue types. 
For example, hematopoietic stem cells (HSCs) are defined as primitive cells that have 
the ability to self-renew and differentiate into all types of blood cells. 
The regulation of stem cell proliferation and differentiation is essential for the 
accurate morphogenesis and maintenance of tissue integrity. Recent studies suggest 
that the unique cell cycle properties of stem cells are functionally important for 
maintaining multipotency. However, molecular mechanisms regulating the cell cycle of 
stem cells are still far from being fully understood partly because of the lack of accurate 
methods for determining and tracking the cell cycle status of individual living cells. 
Fluorescent ubiquitination-based cell cycle indicator (Fucci) technology 
utilizing the cell cycle-dependent proteolysis of ubiquitin oscillators enables 
visualization of cell cycle progression in individual living cells. The Fucci probe consists 
of two chimeric fluorescent proteins, FucciS/G2/M and FucciG1, which label the nuclei of 
cells in S/G2/M phase green and those in G1 phase red, respectively. Fucci technology 
allows us to analyze the spatial and temporal patterns of cell cycle dynamics in vitro 
and in vivo. 
In chapter I, I aimed to investigate cell cycle status of intravital HSCs. I 
generated transgenic mice expressing Fucci probes and analyzed transgene expression 
in hematopoietic cells using flow cytometry. The FucciS/G2/M-#474 and FucciG1-#639 
mouse lines exhibited high-level transgene expression in most hematopoietic cell 
populations. The FucciG1-#610 line expressed the transgene at high levels 
predominantly in the HSC (CD34−KSL: CD34−/lowc-Kit+Sca-1+lineage marker−) 
population. Analysis of the HSC population in the transgenic mice expressing both 
FucciS/G2/M and FucciG1 (#474/#610) confirmed that more than 95% of the cells were in 
G0/G1 phase, although the FucciG1(red) intensity was heterogeneous. An in vivo 
competitive repopulation assay revealed that repopulating activity resided largely in 
the FucciG1(red)high fraction of CD34−KSL cells. Thus, the CD34−KSL HSC population 
can be further purified on the basis of the Fucci intensity. 
In chapter II, I investigated the cell cycle of PSCs. PSCs are classified into two 
distinct pluripotent states: naïve and primed. Naïve and primed PSCs differ in colony 
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morphology, X chromosome inactivation pattern, and requirement of signaling 
pathways for in vitro self-renewal. Most importantly, both naïve and primed PSCs have 
the ability to form teratomas but only naïve PSCs readily contribute to chimera 
formation after blastocyst injection. Thus, primed PSCs represent a more differentiated 
state than naïve PSCs. PSCs have a peculiar cell cycle, which is thought to be involved 
in pluripotency and maintaining undifferentiated state. Therefore, I introduced Fucci 
probes into naïve and primed PSCs using lentiviral vectors and investigated the 
spatio-temporal patterns of cell cycle dynamics in PSCs. A significant number of cells 
with prolonged G1 phase were observed in primed PSCs and the mean length of the G1 
phase of primed and naïve-like PSCs was longer than that of naïve PSCs, suggesting 
that prolonged G1 phase is closely related to the state of PSCs. The prolonged G1 phase 
is probably due to contact inhibition. The G1 phase length had no affect on the length of 
each cell cycle phase in sequential cell division.  
In this study, cell cycle analysis in individual living stem cells using Fucci 
technology revealed heterogeneity in stem cell population, which is involved in stem cell 
function.  
  
3 
 
General Introduction 
 
Stem cells are undifferentiated cells capable of both self-renewal and 
multi-lineage differentiation. Stem cell research is a promising field with attractive 
applications, such as regenerative medicine and drug discovery (Ramakrishna et al., 
2011). Stem cells can be categorized into two types: pluripotent stem cells (PSCs) and 
adult stem cells. 
 
Pluripotent stem cells and adult stem cells 
Pluripotent stem cells (PSCs) can differentiate into all cell types derived from 
the three embryonic germ layers. Embryonic stem cells (ESCs) and induced pluripotent 
stem cells (iPSCs) are well-known PSCs. ESCs are derived from the inner cell mass of 
pre-implantation blastocysts (Evans et al., 1981; Thomson et al., 1988). Although ESCs 
are expected to be exploited in regenerative medicine, use of human ESCs (hESCs) has 
the ethical concerns and the risk of immune rejection after transplantation. Fortunately, 
the problem was resolved by the generation of human iPSCs (hiPSCs) from somatic cells 
by introducing four transcription factors, Oct4, Sox2, Klf4, and c-Myc (Takahashi et al., 
2007). A number of ways to generate and culture hiPSCs have been reported to improve 
safety and efficiency aimed at clinical application (Yamanaka, 2012), but another 
difficulty arises from pluripotent state. 
PSCs can be classified into two distinct pluripotent states: naïve and primed 
(Nichols et al., 2009). Mouse ESCs (mESCs) and iPSCs (miPSCs) represent naïve PSCs, 
which are characterized by compact and domed colony morphology, global reduction in 
DNA methylation, and two active X chromosomes in female. In addition, mESCs/iPSCs 
require external factors leukemia inhibitory factor (LIF) and bone morphogenetic 
protein 4 (BMP4) signaling for in vitro self-renewal (Smith et al., 1988; Ying et al., 2003). 
BMP4 can be replaced by small molecules, MEK inhibitor and GSK3 inhibitor (Olariu et 
al., 2013). Most importantly, mESCs/iPSCs can efficiently contribute to cell types of the 
body including the germline after blastocyst injection.  
On the other hand, mouse epiblast stem cells (mEpiSCs) derived from the 
post-implantation epiblasts represent primed PSCs (Borns et al., 2007). mEpiSCs 
display flattened monolayer colony morphology, increase in DNA methylation, X 
chromosome inactivation in female, and dependence on basic fibroblast growth factor 
(bFGF) and Activin/Nodal signaling for pluripotency and self-renewal. mEpiSCs express 
only some of the pluripotency factors: Oct4, Sox2, and Nanog are highly expressed, 
while Klf4 are expressed in low levels (Silva et al., 2009; Guo et al., 2009). Although 
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mEpiSCs have the ability to form teratomas, they rarely contribute to chimera 
formation after blastocyst injection (Nichols et al., 2009). Unlike mouse PSCs, 
ESCs/iPSCs derived from other species, including humans, rabbits, pigs, and primates, 
are in the primed state. Recent studies have shown that primed PSCs can be converted 
to the naïve-like state that have properties of naïve PSCs expect for the ability to 
contribute to chimeras (Hanna et al., 2010; Honda et al., 2013; Fujishiro et al., 2013; 
Gafni et al., 2013; Theunissen et al., 2014; Takashima et al., 2014). 
In contrast to PSCs, adult stem cells can differentiate into only several lineages. 
For example, hematopoietic stem cells (HSCs) have the ability to self-renew and 
differentiate into all blood cell types (Kondo et al., 2003). HSC transplantation is used to 
treat leukemia and other blood diseases (Shizuru et al., 2005). In this context, ex vivo 
expansion of HSCs would have widespread clinical applications including gene therapy. 
However, the methods for amplification of HSCs without loss of stem cell activity or 
isolation of HSCs with absolute purity have not been achieved. 
 
Cell cycle of pluripotent stem cells 
PSCs have unique cell cycle properties characterized by a rapid proliferation 
with a very short G1 phase (Savatier et al., 1994; White et al., 2005). In general, 
proliferation of somatic cells is responsive to exogenous growth factors. In the absence of 
these signals, somatic cells arrest in G1 phase or enter into quiescent G0 phase. However, 
PSCs are less reliant on exogenous growth factors and are not subject to contact 
inhibition (Savatier et al., 1994; Schratt et al., 2001; Stead et al., 2002). This may be 
owing to an autocrine loop of PSC growth factor signaling, or a cell autonomous mode of 
cell division that does not require such signaling cascades. It has been shown that, 
unlike somatic cells, constitutive Cdk activities in mESCs lead to an inactivation of Rb 
family members, resulting in cell cycle-independent activation of E2F target genes  
(White et al., 2005). Other factors such as miRNAs have also been reported to be 
involved in cell cycle regulation of PSCs (Abdelalim, 2013). It has been hypothesized 
that rapid proliferation of PSCs with the shortened G1 is essential for self-renewal and 
pluripotency (Izpisua et al., 2011; Markossian et al., 2013; Calder et al., 2013). 
 
Cell cycle of hematopoietic stem cells 
The cell cycle of adult stem cells is regulated appropriately. HSCs rapidly 
generate progenitor cells and blood cells during fetal life: more than 95% of HSCs are 
actively cycling in the mouse fetal liver with a cell cycle transit time between 10–14 
hours (Bowie et al., 2006; Nygren et al., 2006). However, in the adult bone marrow (BM), 
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HSC population rapidly switches to a quiescent state by four weeks of age, with only 5% 
of total HSCs actively in the cell cycle thereafter through adult life (Cheshier et al., 
1999; Bowie et al., 2006; Kiel et al., 2007). The balance between HSC quiescence and 
proliferation is thought to be strictly regulated by a complex network of cell-intrinsic 
and cell-extrinsic factors in a specific microenvironment, referred to as the niche 
(Pietras et al., 2011). However, the mechanisms controlling cell cycle activity of HSCs 
are still largely unknown. 
 
Cell cycle analysis and Fucci technology 
The relationship between regulation of cell cycle and potency of stem cells has 
been investigated. However, until recently, cell cycle analysis has been conducted 
mainly by using cell cycle markers or flow cytometry (Nunez et al., 2001; Whitfield et al., 
2006). Detection of markers used in cell cycle studies usually needs the staining, and 
some of them also need the fixation of the cells. Those markers are not suitable for 
intravital cells and long term monitoring of cell cycle. Similarly, flow cytometry can only 
investigate the proportion of each cell cycle phase. Therefore, molecular mechanisms 
regulating the cell cycle of stem cells are still far from being fully understood partly 
because of the lack of accurate methods for determining and tracking the cell cycle 
status of individual living cells. 
Currently, these limits are overcome by the development of fluorescent 
ubiquitination-based cell cycle indicator (Fucci) technology (Sakaue-Sawano et al., 
2008). Fucci technology relies on the precisely regulated cell cycle-dependent proteolysis 
of two factors, Geminin and Cdt1, which ensure that replication occurs only once during 
a cell cycle (Askew et al., 2008). Cdt1 and Geminin are controlled by ubiquitin-mediated 
proteolysis, SCFskp2 and APCCdh1, respectively, displaying mutual antagonism and hence 
reciprocal cell cycle regulated activity (Wei et al., 2004; Benmaamar et al., 2005). Cdt1 
protein accumulates during G1 but ubiquitinated for subsequent degradation by the 
SCFskp2 complex at the onset of S phase and thus absent throughout S/G2/M (Carlier et 
al., 2014). On the other hand, Geminin accumulates during S and G2, but targeted for 
ubiquitin-mediated proteolysis by the APCCdh1 complex when cell exit mitosis and G1 
phase (Carlier et al., 2014). FucciG1 probe is a fusion protein of a fragment of human 
Cdt1 with the red fluorescent that indicates the G1 phase. FucciS/G2/M probe is a 
fusion protein of a fragment of human Geminin with the green fluorescent protein that 
visualizes S, G2 and M phases (Sakaue-Sawano et al., 2008). Generating stable cell 
lines and transgenic mice that constitutively express Fucci probes allows us to analyze 
the spatio-temporal patterns of cell cycle dynamics (Sakaue-Sawano et al., 2013).  
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By taking advantage of Fucci technology, this study aimed to investigate the 
cell cycle of stem cells. In chapter I, I investigated cell cycle status of intravital HSCs 
using transgenic mice expressing Fucci probes. In chapter II, I introduced Fucci probes 
into PSCs using lentiviral vectors and investigated the spatio-temporal patterns of cell 
cycle dynamics in PSCs.  
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Chapter I 
 
 
Generation and characterization of transgenic mice expressing Fucci probes 
for cell cycle analysis of hematopoietic cells 
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Introduction 
 
 Hematopoiesis is a hierarchical differentiation process by which all blood cell 
types are generated from hematopoietic stem cells (HSCs). HSCs are capable of 
self-renewal and multilineage differentiation. In the adult bone marrow (BM), HSCs are 
predominantly quiescent and reside in a specific microenvironment, referred to as the 
niche, where HSC quiescence, self-renewal, proliferation, and differentiation are 
thought to be strictly regulated in order to maintain the HSC pool and sustain lifelong 
production of blood cells (Morrison SJ et al., 2014). HSCs give rise to highly proliferative 
progenitors with limited or no self-renewal capacity and lineage-restricted 
differentiation potential, producing terminally differentiated hematopoietic cells. Cell 
cycle regulation plays a critical role in hematopoiesis (Pietras EM et al., 2011). Although 
many intrinsic and extrinsic factors are involved in hematopoiesis, the regulatory 
mechanisms underlying hematopoietic cell proliferation and differentiation are still 
unclear. Visualizing the progress of the cell cycle in hematopoietic cells including HSCs 
will provide valuable information for better understanding how cell cycle progression 
and hematopoiesis are coordinated. 
 Fluorescent ubiquitination-based cell cycle indicator (Fucci) technology makes 
it possible to visualize cell cycle progression in living cells ( Sakaue-Sawano et al., 2008). 
This technology utilizes the cell cycle-dependent proteolysis of two ubiquitin oscillators, 
human Cdt1 and geminin. The original Fucci probe was generated by fusing monomeric 
Kusabira Orange 2 (mKO2) and monomeric Azami Green (mAG) to the ubiquitination 
domains of Cdt1 (hCdt1(30/120)) and geminin (hGem(1/110)), respectively. The resulting 
mKO2-hCdt1(30/120) and mAG-hGem(1/110) fusion proteins label the nuclei of cells in 
G1 phase red and those in S/G2/M phase green, respectively. Using Fucci probes, the cell 
cycle behavior of individual cells was visualized in vitro and in vivo (Hama H et al., 
2011; Ge WP et al., 2012; Juuri E et al., 2012; Sakaue-Sawano et al., 213).  
 In this study, transgenic mice expressing Fucci probes were generated and I 
analyzed transgene expression in hematopoietic cells including HSCs. I also analyzed 
the relationship between Fucci signal intensity and repopulating activity of HSCs. 
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Materials and methods 
 
Fucci transgenic mice 
 Generation of Fucci transgenic mice expressing mAG-hGem(1/110) and 
mKO2-hCdt1(30/120) under the control of the CAG promoter has been reported 
previously ( Sakaue-Sawano A et al., 2008). Transgenic mouse lines (FucciS/G2/M-#474, 
-#492, -#504 and FucciG1-#596, -#610, -#639) were backcrossed to C57BL/6N (B6-Ly5.2) 
mice for more than ten generations and can be obtained from RIKEN BioResource 
Center (Tsukuba, Japan). All animal experiments were approved by the Animal 
Experiment Committee at the RIKEN Tsukuba Institute. 
 
Analysis of transgene expression 
 Hematopoietic cells were isolated from BM, peripheral blood (PB), spleen, and 
thymus of Fucci transgenic mice (3-6 months of age). The cells were stained with cell 
surface marker antibodies. The following antibodies were used: APC-, APC-Cy7-, 
PE-Cy7, or PerCP-Cy5.5-conjugated anti-B220, anti-CD3, anti-CD4, anti-CD8, 
anti-NK1.1, anti-Gr-1, anti-Mac-1, anti-CD41, anti-Ter119, anti-c-Kit, anti-Sca-1, 
anti-FcγR, anti-IL-7Ra, and anti-CD34 (all antibodies purchased from eBioscience, San 
Diego, CA). Lineage marker (Lin) antibodies consist of biotinylated anti-Gr-1, 
anti-Mac-1, anti-B220, anti-IgM, anti-CD4, anti-CD8, and anti-Ter119. The biotinylated 
antibodies were developed with APC-Cy7-conjugated streptavidin (eBioscience). 
Fluorescence-activated cell sorting (FACS) analysis was performed with a FACSCalibur 
or a FACSAriaIII equipped with four lasers (405, 488, 561, and 633 nm) (BD Biosciences, 
San Jose, CA). 
 
Competitive repopulation assay 
 B6-Ly5.2 mice were purchased from Charles River Laboratories Japan. 
B6-Ly5.1 mice were obtained from RIKEN BioResource Center. B6-Ly5.1/Ly5.2 F1 mice 
were obtained by mating pairs of B6-Ly5.1 and B6-Ly5.2 mice. BM cells isolated from 
Fucci transgenic mice (B6-Ly5.2) were stained with biotinylated Lin antibodies. The 
cells were then stained with eFluor660-conjugated anti-CD34, PE-Cy5.5-conjugated 
anti-Sca-1, and PE-Cy7-conjugated anti-c-Kit antibodies (eBioscience). The biotinylated 
antibodies were developed with APC-eFluor780-conjugated streptavidin (eBioscience). 
Twenty FACS-sorted FucciG1(red fluorescence)high or FucciG1(red fluorescence)low 
CD34−/lowc-Kit+Sca-1+Lin− (CD34−KSL) cells were mixed with 2 × 105 total BM 
competitor cells from B6-Ly5.1/5.2 F1 mice and transplanted into lethally (9.5 Gy) 
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irradiated B6-Ly5.1 mice. At various time points after transplantation, PB cells of the 
recipient mice were collected and stained with biotinylated anti-Ly5.2 (BD Biosciences), 
APC-conjugated anti-Ly5.1, PE-Cy7-conjugated anti-Mac-1, PE-Cy7-conjugated 
anti-Gr-1, PE-Cy7-conjugated anti-B220, eFluor450-conjugated anti-CD4, and 
eFluor450-conjugated anti-CD8 antibodies (eBioscience). The biotinylated antibody was 
developed with APC-eFluor780-conjugated streptavidin. FACS analysis was performed 
with a FACSAriaIII. Donor chimerism was determined as the percentage of Ly5.2+ cells. 
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Results 
 
Analysis of transgene expression in hematopoietic cells of Fucci transgenic mice 
 Generation of eight transgenic mice expressing mAG-hGem(1/110) 
(FucciS/G2/M) and 16 transgenic mice expressing mKO2-hCdt1(30/120) (FucciG1) has 
been reported previously ( Sakaue-Sawano A et al., 2008). Analysis of whole body 
sections from newborn mice revealed high-level transgene expression in FucciS/G2/M 
transgenic mouse lines (#474, #492, #504, and #514) and FucciG1 lines (#596, #610, 
#639, and #659). Then, these eight mouse lines were further analyzed by FACS for the 
transgene expression in various hematopoietic cell populations of BM cells (Figure 1-1). 
The Fucci transgenes were expected to be highly expressed apparently in all tissues of 
the FucciS/G2/M-#504 and FucciG1-#596 lines ( Sakaue-Sawano A et al., 2008). However, 
the FACS data indicated that these two lines and FucciG1-#659 line expressed 
transgenes at very low levels in all hematopoietic cell populations we analyzed. 
 FucciS/G2/M-#474 had the highest transgene expression in most hematopoietic 
cell populations. Note that high-level transgene expression was observed preferentially 
in B lymphoid cells from FucciS/G2/M-#492 mice. FucciS/G2/M-#492 was successfully 
used to visualize the localization of activated proliferating memory B cells in the spleen 
(Aiba Y et al., 2010). FucciG1-#610 and FucciG1-#639 expressed the transgene at high 
levels, especially in HSCs (CD48−KSL or CD34−KSL) and mature hematopoietic cell 
populations, respectively. 
 Next, I generated transgenic mice expressing both FucciS/G2/M and FucciG1 by 
cross-breeding FucciS/G2/M-#474 with FucciG1-#610, and analyzed transgene 
expression in cells from various hematopoietic organs. As shown in Figure 1-2, 
transgene expression was detected in mature hematopoietic cell populations from the 
PB, BM, spleen, and thymus. As expected, the number of FucciG1(red)-positive cells 
increased with differentiation from immature to mature cells (e.g., immature CD4+CD8+ 
T cells vs. mature CD4+CD8− or CD4−CD8+ T cells in the thymus). On the other hand, 
the number of FucciS/G2/M(green)-positive cells increased with the differentiation of 
HSCs into multipotent progenitors (MPPs) and lineage-restricted progenitors, common 
lymphoid progenitors (CLPs), common myeloid progenitors (CMPs), 
granulocyte/macrophage progenitors (GMPs), and megakaryocyte/erythrocyte 
progenitors (MEPs). 
 
3.2. Analysis of Fucci fluorescence intensity and repopulating activity of HSCs 
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 Next, I analyzed the HSC population of #474/#610 mice in detail. More than 
95% of CD34−KSL cells were FucciG1(red)-positive (Fig. 1-3a), confirming that HSCs are 
predominantly in G0/G1 phase. Interestingly, heterogeneous fluorescence intensities 
were found in the FucciG1(red)-positive population. The proportion of FucciG1(red)high 
cells was significantly higher in the HSC (CD34−KSL) population than in the MPP 
(CD34+KSL) population. This finding suggests that FucciG1(red)high cells are in more 
quiescent or stay longer in G0/G1 phase than FucciG1(red)low cells. The FucciG1(red) 
intensity was also heterogeneous in other HSC populations using CD150 and CD48 
markers (Kiel MJ et al., 2005) (Supplementary Fig. 1-5), although these HSC 
populations substantially overlap with each other (Ema H et al., 2006; Morita Y et al., 
2013; Mayle A et al., 2013). 
 To assess whether FucciG1 expression status correlates with repopulating 
activity, the FucciG1(red)high or FucciG1(red)low fraction of CD34−KSL cells was sorted by 
FACS (Fig. 1-3b) and subjected to an in vivo competitive repopulation assay. As shown 
in Figure 1-3c, repopulating activity was found to reside mainly in the FucciG1(red)high 
cell population. I also cultured FucciG1(red)high and FucciG1(red)low CD34−KSL cells in 
vitro with a combination of cytokines (stem cell factor, thrombopoietin, fibroblast 
growth factor-1, and insulin-like growth factor-2) (Noda S et al., 2008). No significant 
differences were found in the timing of the first cell division and the duration of the cell 
cycle between these two cell populations (data not shown). The cell cycle state of 
CD34−KSL cells appears to not influence the induction of cell proliferation under the in 
vitro culture conditions. 
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Discussion 
 
 I generated Fucci transgenic mouse line #474/#610 expressing both 
FucciS/G2/M and FucciG1 in various hematopoietic cells, especially HSCs. Thus, 
#474/#610 mice are useful for studying the cell cycle dynamics of HSC differentiation 
into mature hematopoietic cells. Using #474/#610 mice, we were able to visualize 
endomitosis in megakaryoblasts differentiated from HSCs, MPPs, CMPs, and MEPs 
(Sakaue-Sawano A et al., 2013). It would be interesting to analyze hematopoietic cell 
cycle dynamics in mice generated by crossing #474/#610 mice with mutant mice 
associated with hematopoietic abnormalities in future studies.  
 It is generally accepted that HSCs in the adult BM are almost exclusively in 
quiescent G0 phase. The results with Fucci probe also suggest that most HSCs remain 
in G0/G1 phase. FucciG1(red)high cells in HSC populations appear to be in G0 phase for a 
long period of time, but the Fucci probe used in this study cannot distinguish between 
G0 and G1 phase. Recently, a fusion protein of the fluorescent protein mVenus and a 
p27K− mutant lacking CDK inhibitory activity (mVenus-p27K−) was shown to be 
capable of visualizing cells in G0 phase (Oki T et al., 2014). In combination with Fucci 
probe, mVenus-p27K− probe is also capable of distinguishing between cells in G0 phase 
and cells in G1 phase during the G0–G1 transition. Therefore, the relationship between 
FucciG1(red) intensity and duration of G0 phase in HSC populations could be analyzed 
using mVenus-p27K− probe. Unfortunately, the expression of mVenus-p27K− was 
reported to be low or undetectable in hematopoietic cells from mVenus-p27K− transgenic 
mice. However, time-lapse analysis of HSC division in the BM niche of mice 
transplanted with HSCs expressing Fucci and mVenus-p27K− probes, if possible (Celso 
CL et al., 2009; Xie Y et al., 2009; Kohler A et al., 2009), will provide valuable 
information about HSC biology.  
 Purification of HSCs is important when studying their self-renewal and 
differentiation, especially at a clonal level. Substantial progress has been made in 
isolating murine HSCs using a combination of cell surface markers and flow cytometry. 
CD34−KSL cells are highly purified HSCs. However, single-cell transplantation studies 
identified only 20–40% of CD34−KSL cells as long-term repopulating cells (Ema H et al., 
2006; Noda S et al., 2008; Osawa M et al., 1996; Ema H et al., 2000; Takano H et al., 
2004). Because the seeding efficiency is thought to be more than 50% (Ema H et al., 
2006), CD34−KSL cells are still not a pure population of HSCs. In the present study, we 
demonstrated that the fluorescence intensity of FucciG1(red) can be used for further 
purification of CD34−KSL HSCs, and probably other HSC populations such as 
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CD150+CD48−KSL and CD34−CD150+KSL cells. Adult HSC-specific properties, 
including cell cycle quiescence, are altered during ontogeny and aging ( Pietras EM et 
al., 2011; Boisset JC et al., 2012; Geiger H et al., 2013). In addition, recent studies have 
identified functionally distinct HSC subtypes, including myeloid-biased, 
lymphoid-biased, and balanced HSCs (Copley MR et al., 2012). Thus, Fucci transgenic 
mice are expected to facilitate further characterization of HSCs with distinct properties 
in terms of their cell cycle status. 
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Chapter II 
 
Cell cycle analysis of pluripotent stem cells using Fucci probes 
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Introduction 
 
 Pluripotent stem cells (PSCs) have the ability to self-renew and differentiate 
into all cell types of the body. PSCs can be classified into two distinct pluripotent states: 
naïve and primed (Nichols et al., 2009) (Fig. 2-1).  
Mouse embryonic stem cells (mESCs) (Evans et al., 1981) and induced 
pluripotent stem cells (miPSCs) (Takahashi et al., 2006) represent naïve PSCs, which 
are characterized by compact and domed colony morphology, global reduction in DNA 
methylation, two active X chromosomes in female, and requirement of leukemia 
inhibitory factor (LIF) and bone morphogenetic protein 4 (BMP4) signaling pathways 
for in vitro self-renewal (Smith et al., 1988; Ying et al., 2003). In addition, mESCs/iPSCs 
can efficiently contribute to cell types of the body including the germline after blastocyst 
injection.  
On the other hand, mouse epiblast stem cells (mEpiSCs) derived from the 
post-implantation epiblasts represent primed PSCs (Borns et al., 2007). mEpiSCs 
display flattened monolayer colony morphology, increase in DNA methylation, X 
chromosome inactivation in female, and dependence on basic fibroblast growth factor 
(bFGF) and Activin/Nodal signaling for pluripotency and self-renewal. Although 
mEpiSCs have the ability to differentiate into cells of all three germ layers in vitro and 
give rise to differentiated teratomas, they rarely contribute to chimera formation after 
blastocyst injection (Nichols et al., 2009). Unlike mouse PSCs, ESCs/iPSCs derived from 
other species, including humans, rabbits, pigs, and primates, are classified as the 
primed state.  
Recent studies have shown that primed PSCs can be converted to the 
naïve-like state by expressing exogenous genes and/or cultivation with small molecules 
and cytokines (Hanna et al., 2010; Honda et al., 2013; Fujishiro et al., 2013; Gafni et al., 
2013; Theunissen et al., 2014; Takashima et al., 2014). These naive-like PSCs exhibit 
the naive state properties, but they have a limited capacity for producing chimeric 
offspring. Because it is not allowed to produce human chimeras, appropriate markers 
are required to evaluate the state of human PSCs in vitro.  
 PSCs have unique cell cycle features. Cultured mESCs exhibit a high rate of 
proliferation and a short cell cycle time (10-12 hours) (Stead et al., 2002). Similarly, 
hESCs and hiPSCs have a short G1 phase (2-3 hours) and an abbreviated cell cycle 
(16-18 hours) (Becker et al., 2006; Fluckiger et al., 2006; Ghule et al., 2011). A short G1 
phase is a characteristic of the PSCs (Ruiz et al., 2011). This short G1 phase is 
associated with a unique mechanism of cell cycle regulation (Suvorova et al., 2012). 
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Generally, cell fate is determined during G1 phase the mammalian cell cycle (Blomen et 
al., 2007; Pfeuty et al., 2008). Recent studies suggest that a short G1 phase might be 
involved in actively sustaining the pluripotent state (Calder et al., 2013; Coronado et al., 
2013; Singh et al., 2013). However, heterogeneity of PSCs and spatio-temporal patterns 
of cell cycle dynamics have not yet been investigated.  
 In this study, I introduced fluorescent ubiquitination-based cell cycle indicator 
(Fucci) probes (Sakaue-Sawano et al., 2008) into PSCs using lentiviral vectors and 
measured the length of each cell cycle phase in individual cells by time-lapse imaging. 
In addition, I compared the length of each cell cycle phase in sequential cell division. I 
also analyzed the influence of cell density on cell cycle progression.  
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Materials and Methods 
 
Cell lines 
 Mouse ESCs (mESCs) (ROSA-mES), rabbit ESCs (rESCs) (rES8-2), rabbit 
iPSCs (riPSCs) (iPS-S1), naïve-like riPSCs (l-iPS-S) were obtained from Bioresource 
Engineering Division, BioResource Center, RIKEN. Human ESCs (hESCs) (hES-H1) 
and normal human skin fibroblasts (NB1RGB) were obtained from CELL BANK, 
BioResource Center, RIKEN. Human hiPSCs (hiPSCs) (hiPS-PDL24) were generated 
from NB1RGB by introducing hOCT3/4, hSOX2, hKLF4, and hMYC using lentiviral 
vectors (Fujioka et al., 2010). Mouse iPSCs (miPSCs) (ROSA-miPS) were generated 
from mouse embryonic fibroblast (ROSA-MEF) by introducing mOct3/4, mSox2, mKlf4, 
and m-Myc using lentiviral vectors. All of those cell lines were validated to form 
teratomas and expressed the endogenous pluripotent markers. 
 
Cell culture 
 Primed PSCs were plated onto mitomycin-C-treated MEF at a concentration of 
6×103/cm (rESCs, riPSCs), 2×104/cm (hESCs, hiPSCs) on the 0.1% gelatin coated dish. 
The culture medium of primed PSCs was generated by including 78% DMEM/F12 
(Invitrogen), 20% KSR (Invitrogen), 2mM L-Glutamine (Invitrogen), 0.1mM NEAA 
(Invitrogen), 0.1mM 2-Mercaptoethanol (Sigma), 8ng/ml bFGF (Wako). Passage of 
hESCs and hESCs was performed by dissociated solution including 0.25% trypsin, 0.1% 
collagenase type IV, 20% KSR, 1mM CaCl2, PBS(-). Passage of rESCs and rESCs was 
performed by 0.25% Trypsin-EDTA (Invitrogen). Naïve and naïve-like PSCs were plated 
onto mitomycin-C-treated MEF at a concentration of 4×104/cm on the 0.1% gelatin 
coated dish. The culture medium of naïve and naïve-like PSCs was generated by 
including 48% DMEM/F12 (Invitrogen), 48% Neurobasal (Invitrogen), 1% N2 
supplement (Invitrogen), 2% B27 supplement (Invitrogen), 10 ng/ml recombinant 
human LIF (WAKO), 2mM L-Glutamine (Invitrogen), 0.1mM NEAA (Invitrogen), 
0.1mM 2-Mercaptoethanol (Sigma), 5 mg/mL BSA (Sigma), 1 μM PD0325901 (WAKO), 3 
μM CHIR99021 (WAKO) (and 10 μM Forskolin (WAKO) in case of naïve-like PSCs). 
Passage of naïve and naïve-like PSCs was performed by 0.25% Trypsin-EDTA 
(Invitrogen) 
 
Conversion of hiPSCs to naive-like hiPSCs 
 Naïve-like hiPSCs (nhiPS-2iOF) were generated from hiPS-PDL24 using 
established methods (Hanna et al., 2010; Honda et al., 2013). hiPSCs were transduced 
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by a lentiviral vector expressing hOCT3/4-IRES-Venus. About one week after, 
Venus-positive cells were sorted or picked up, and cultured about one week in primed 
PSCs medium. After colony formation, culture medium was replaced by naïve medium 
contained forskolin, and naïve PSCs-like colonies were picked up. 
 
Conversion of miPSCs to mEpiSCs 
 mEpiSCs (mEpiSC-derived-iPS) were differentiated from ROSA-miPSCs using 
established methods (Brons et al., 2007; Turco et al., 2012). Briefly, miPSCs were plated 
onto mitomycin-C-treated MEF at a concentration of 2×104/cm on the 15 μg/ml of 
human fibronectin coated dish. mEpiSCs were cultured on naïve PSCs medium 
supplemented with 10 ng/ml Activin (R&D systems) and 12ng/ml bFGF (Wako), instead 
of PD0325901, CHIR99021 and LIF. mEpiSCs were passaged every three days with 
dissociated solution at least seven times. 
 
Lentiviral vectors 
 Replication-defective, self-inactivating lentiviral vectors were used (Miyoshi et 
al., 1998). Fucci cDNA: mCherry-hCdt1(30/120), mCherry-hCdt1(1/100)_CyAAA, 
mVenus-hGem(1/110), and AmCyan-hGem(1/110) were cloned into the CSII-EF-MCS 
vector. Reprogramming factor cDNAs: hOct3/4, hSox2, hKlf4, and h-Myc were cloned 
into the CSII-EF-MCS-IRES-Venus vector. The vector plasmid was co-transfected with 
the packaging plasmid (pCAG-HIVgp) and the VSV-G into 293T cells. High-titer viral 
solutions for each cDNA were prepared and used for co-transduction into the cell lines. 
 
Time-lapse imaging and analysis of Cell Cycle 
 After infection of lentiviral vectors, PSCs were analyzed and sorted using BD 
LSR II and FACS Aria III (Becton Dickinson). Sorted PSCs were cultured on CELLview 
35 mm glass bottom dish (Greiner) coated 0.1% gelatin or 15 μg/ml of human fibronectin. 
Time-lapse imaging was performed using a computer-assisted fluorescence microscope, 
LCV110 (Olympus), FV1000d(Olympus), or BZ-9000 (KEYENCE). Image acquisition 
and analysis were performed using MetaMorph (Universal Imaging, Media, PA), 
FLUOVIEW Viewer (Olympus ), Image J (Schneider et al., 2012), and R software (Jobb 
et al., 2004). 
 
 
 
  
20 
 
Results 
 
Cell cycle analysis of PSCs 
 To analyze cell cycle of naïve PSCs (mESCs/miPSCs) and primed PSCs 
(mEpiSCs, hESCs/hiPSCs, and rESCs/riPSCs), PSCs were transduced with lentiviral 
vectors expressing Fucci4 probes under the EF-1 promoter. Fucci4 probes consists of two 
chimeric proteins: mCherry-hCdt1(1/100)_CyAAA and AmCyan-hGeminine(1/110), 
which labels G1 phase nuclei red, S phase nuclei blue, and G2/M phase nuclei red and 
blue (Fig. 2-2). PSCs expressed Fucci4 probes at moderate levels were isolated and 
time-lapse imaging was performed for 48-72 hours.  
  After processing time-lapse imaging movies (Fig 2-5), I measured the length of 
each cell cycle phase in individual mouse PSCs. As expected, a prolonged G1 phase was 
observed in a significant number of mEpiSCs (Fig 2-6), and the mean length of the G1 
phase of mEpiSCs (3.03±1.45 h) was significantly longer than that of mESCs (2.41±0.79 
h) and miPSCs (2.35±0.74 h) (Table 1). On the other hand, there was not much 
difference in the length of S and G2/M phases between mESCs/miPSCs and mEpiSCs. 
In human PSCs (hESCs/hiPSCs) (Fig. 2-7, 8), a significant number of cells with 
prolonged G1 phase were also observed (Fig. 2-9). The mean length of the G1 phase of 
hESCs (3.50±1.09 h) and hiPSCs (4.31±1.85 h) was longer than that of mEpiSCs 
(Table 1), but distributions of the G1 length were similar to mEpiSCs. In rabbit PSCs 
(rESCs/riPSCs) that can be dissociated into single cells as in naïve PSCs (Fig. 2-10, 11), 
the mean length of the G1 phase of rESCs (3.02±0.75 h) and riPSCs (2.93±1.28 h) was 
similar to that of mEpiSCs (Table 1), but the number of cells with prolonged G1 phase 
was decreased as compared to mEpiSCs and hESCs/iPSCs (Fig. 2-12). Again, there was 
not much difference in the length and distribution of S and G2/M phases among 
hESCs/hiPSCs and rESCs/riPSCs. Similar results were obtained with hiPSCs using 
Fucci2 probes.  
 Next, I generated naïve-like hiPSCs that can be dissociated into single cells 
(Fig. 2-14). Fucci4 probes were introduced into naïve-like hiPSCs and riPSCs using 
lentiviral vectors, and time-lapse imaging was performed (Fig. 2-15, 16). The mean 
length of the G1 phase of naïve-like hiPSCs (3.31±1.29 h) and naïve-like riPSCs 
(3.26±0.81 h) was shorter than corresponding primed iPSCs (Table 1) though cells with 
prolonged G1 phase were still observed (Fig. 2-17). 
 
Comparison of the G1 phase length in sequential cell division 
 Next, I compared the length of the G1 phase in sequential cell division of 
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hiPSCs. No correlation was observed in the length of the G1 phase in three sequential 
G1 phases or in two daughter cells derived from the same mother cell (Fig. 2-18). No 
correlation was also observed between the G1 phase and S or G2/M phases in individual 
cells (Fig. 2-19). Similar results were obtained with other naïve and primed PSCs (data 
not shown). These results indicated that the G1 phase length had no affect on the length 
of each cell cycle phase in sequential cell division.  
 
Correlation between the cell density and the prolonged G1 phase 
 In hiPSCs and mEpiSCs, cells with prolonged G1 phase were frequently 
observed in the middle of the colony where the cell density is higher than other locations 
(Fig. 2-20). Therefore, correlation between the cell density and the length of the G1 
phase was analyzed. The cell density is defined as the number of cells within a circle 
with 20, 30, or 40 μm diameter from a selected cell in each time-lapse frame (Fig. 2-21, 
22). The average cell density was calculated during the G1 phase or S/G2/M phases in 
each time-laps frame (Fig. 2-23a).  
The G1 phase length was likely to increase in proportion to the cell density (Fig. 
2-23b). No correlation was observed between the cell density and the length of the 
S/G2/M phases. The results suggest that the prolonged G1 phase is due to contact 
inhibition.  
To compare with differentiated somatic cells, Fucci2 probes (Fig. 2-2) were 
introduced into HeLa (human epithelial carcinoma cell line) and NMuMG (normal 
mouse mammary epithelial cell line) using lentiviral vectors, and time-lapse imaging 
was performed (Fig. 2-24, 25). The G1 phase length increased in direct proportion to the 
cell density in HeLa and NMuMG cells as expected (Fig. 2-26a, b). There was a clear 
difference between hiPSCs and HeLa or NMuMG in terms of the cell density effect on 
the G1 phase length. The G1 phase length of hiPSCs also increased substantially with 
increasing cell density, but cells with a short G1 phase also exist at high cell density (Fig. 
2-26c). The G1 phase length of human iPS cells is significantly shorter than that of 
HeLa and NMuMG cells at high cell density. Because of the technical difficulties, it was 
not possible to measure the cell density of naïve PSCs with compact and domed colony 
morphology, but no correlation between the cell density and the G1 phase length is 
predicted (Fig. 2-26d).  
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Discussion 
 
 It has been demonstrated that PSCs have unique cell cycle properties 
characterized by a rapid proliferation with a very short G1 phase (Savatier et al., 1994; 
White et al., 2005), suggesting a functional correlation with self-renewal and 
pluripotency (Calder et al., 2013; Coronado et al., 2013; Singh et al., 2013). However, 
cell cycle of PSCs has not been analyzed in detail at single cell levels.  
In this study, I measured the length of each cell cycle phase in individual PSCs 
by time-lapse imaging with Fucci probes. The results showed that the mean length of 
the G1 phase of primed PSCs was significantly longer than that of naïve PSCs. 
Heterogeneity was found largely in primed PSCs, in which a significant number of cells 
with prolonged G1 phase were observed. In addition, the mean length of the G1 phase of 
naïve-like iPSCs was shorter than corresponding primed iPSCs though cells with 
prolonged G1 phase were also observed. Intriguingly, there is no correlation in the 
length of the G1 phase between mother and daughter cells. Taken together, the results 
suggest that the prolonged G1 phase is closely related to the state of PSCs.  
  In general, proliferation of differentiated somatic cells is responsive to 
exogenous proliferation signals. Excessive proliferation signals through cell-cell 
interactions arrest cells in G1 phase or enter cells in quiescent G0 phase (Fig. 2-27). It 
has been suggested that contact inhibition is induced by E-cadherin mediated cell-cell 
contact and intracellular signal transduction pathway (Navarro et al., 1991; Aoki K et 
al., 2013). In contrast, naïve PSCs (mESCs) are less reliant on exogenous growth factors 
and are not subject to contact inhibition (Savatier et al., 1994; Schratt et al., 2001; 
White et al., 2005) (Fig. 2-28). This may be owing to an autocrine loop of PSC growth 
factor signaling, or a cell autonomous mode of cell division that does not require such 
signaling cascades. It has been shown that, unlike somatic cells, constitutive Cdk 
activities in mESCs lead to an inactivation of Rb family member proteins. This results 
in cell cycle-independent expression of E2F-regulated genes (White et al., 2005). On the 
other hand, my results showed that the G1 phase length of some but not all primed 
PSCs (hiPSCs and mEpiSCs) is affected by the cell density (Fig. 2-29). Therefore, the 
prolonged G1 phase cased by contact inhibition may exhibit some differences in cell cycle 
regulation between naïve and primed PSCs. Indeed, it has been reported that naïve and 
primed PSCs differ in global gene expression patterns including micro RNAs, X 
chromosome inactivation pattern, and signaling pathways required for self-renewal 
(Nichols J et al., 2009).  
In conclusion, the results in this study suggest that a short G1 phase, which is 
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not affected by the cell density, can be a novel feature of naïve state and might be useful 
as a marker for evaluation of the state of PSCs in vitro (Fig. 2-30). 
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Figure 1-1. FACS analysis of transgene expression in hematopoietic cells of FucciS/G2/M 
and FucciG1 transgenic mice. BM cells were isolated from FucciS/G2/M transgenic 
mouse lines (#474, #492, #504, and #514) and FucciG1 lines (#596, #610, #639, and 
#659). The cells were stained with cell surface marker antibodies, and 
FucciS/G2/M(mAG) or FucciG1(mKO2) transgene expression was analyzed by flow 
cytometry. Shown are representative FACS profiles of (A) whole BM, erythroid (Ter119+), 
myeloid (Gr-1+ or Mac-1+), B-lymphoid (B220+), T-lymphoid (CD4+ or CD8+), (B) Lin−, 
c-Kit+Lin−, KSL, CD48+KSL, CD48−KSL, and CD34−KSL cells 
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Figure 1-2. FACS analysis of transgene expression in hematopoietic cells of Fucci 
transgenic mouse line #474/#610. Hematopoietic cells were isolated from BM, spleen, 
PB, and thymus of Fucci transgenic mouse line #474/#610 and stained with cell surface 
marker antibodies. FucciS/G2/M(mAG) and FucciG1(mKO2) transgene expression was 
analyzed by flow cytometry. Representative FACS profiles of hematopoietic 
subpopulations are shown. Gating for hematopoietic subpopulations are shown in 
Figure 1-4. 
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Figure 1-3. FucciG1 fluorescence intensity and repopulating activity of HSCs from Fucci 
transgenic mouse line #474/#610. (A) FACS profiles of HSC (CD34−KSL) and MPP 
(CD34+KSL) populations of BM cells from Fucci transgenic mice (#474/#610). 
FucciG1(red)high and FucciG1(red)low populations are indicated. (B) Representative 
fluorescence and DIC images of FACS-sorted FucciG1(red)high and FucciG1(red)low 
CD34−KSL cells. (C) Twenty FACS-sorted FucciG1(red)high or FucciG1(red)low CD34−KSL 
cells were subjected to a competitive repopulation assay. At the indicated time points 
after transplantation, PB cells of the recipient mice were analyzed by flow cytometry, 
and donor chimerism was determined. Data from two independent transplantation 
experiments are shown (n = 5 or 6 mice per experiment). 
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Figure 1-4. Gating for FACS analysis of transgene expression in hematopoietic 
subpopulations. Hematopoietic cells were isolated from BM, spleen, PB, and thymus of 
Fucci transgenic mouse line #474/#610 and stained with cell surface marker antibodies 
as described in Materials and Methods. Shown are representative gating for 
hematopoietic subpopulations: B-lymphoid cells (B220+IgM+), T-lymphoid cells (CD3+, 
CD4−CD8−, CD4+CD8−, CD4−CD8+, and CD4+CD8+), NK cells (NK1.1+), granulocyte 
(Gr-1+Mac-1+), monocyte (Gr-1−Mac-1+), megakaryocyte (CD41+), erythroid cells 
(Ter119+), HSCs (CD34−/lowc-Kit+Sca-1+Lin−), MPPs (CD34+c-Kit+Sca-1+Lin−), CLPs 
(c-KitmidSca-1midLin−IL- +), CMPs (CD34+c-Kit+Sca-1−Lin− −), GMPs 
(CD34+c-Kit+Sca-1−Lin− +), and MEPs (CD34−c-Kit+Sca-1−Lin− −). 
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 Figure 1-5. FucciG1 fluorescence intensity of HSC populations in Fucci transgenic 
mouse line #474/#610. BM cells of Fucci transgenic mouse line #474/#610 were stained 
with the following antibodies: biotinylated anti-lineage markers, PE-Cy5.5-conjugated 
anti-Sca-1, APC-eFluor780-conjugated anti-c-Kit, eFluor660-conjugated anti-CD34, 
eFluor450-conjugated anti-CD48, and PE-Cy7-conjugated CD150 (all antibodies 
purchased from eBioscience). The biotinylated antibodies were developed with 
V500-conjugated streptavidin (BD Biosciences). The stained cells were analyzed with a 
FACSAriaIII equipped with four lasers (405, 488, 561, and 633 nm). Representative 
FACS profiles of HSC populations are shown. 
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Modified Fujishiro S et al. (2013)  
 
Figure 2-1. Naïve and primed PSCs. In mice, mESCs are derived from the inner cell 
mass of pre-implantation blastocysts and readily contribute to chimera formation after 
blastocyst injection (naive state). mEpiSCs are derived from the post-implantation 
epiblasts. mEpiSCs are also pluripotent stem cells, but they rarely contribute to 
chimera formation (primed state). Unlike mouse PSCs, ESCs/iPSCs derived from other 
species, including humans, rabbits, pigs, and primates, are classified as the primed 
state. 
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Figure 2-2. Fucci2 and Fucci4. (a) Fucci2 probes consists of mCherry-hCdt1(1/100) and 
mVenus-hGeminine(1/110). The combinations of fluorescence color and cell cycle phases 
are G1-red, S/G2/M-green, and G1/S-red and green. (b) Fucci4 consists of 
mCherry-hCdt1(1/100)_CyAAA and AmCyan-hGeminine (1/110). The combinations of 
fluorescence color and cell cycle phases are G1-red, S-blue, and G2/M-red and blue. 
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Figure 2-3. Time-lapse imaging of mESCs using Fucci4 probes. Time-lapse imaging of 
mESCs was performed with FV1000-D confocal microscope for 63 hours. Since Fucci4 
probes were used in this imaging, the combinations of fluorescence color and each cell 
cycle phase are G1-red, S-blue, and G2/M-red and blue (the color is processed to white). 
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Figure 2-4. Time-lapse imaging of miPSCs using Fucci4 probes. Time-lapse imaging of 
mESCs was performed with FV1000-D confocal microscope for 63 hours. Since Fucci4 
probes were used in this imaging, the combinations of fluorescence color and each cell 
cycle phase are G1-red, S-blue, and G2/M-red and blue (the color is processed to white). 
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Figure 2-5. Time-lapse imaging of mEpiSCs using Fucci4 probes. Time-lapse imaging of 
mESCs was performed with FV1000-D confocal microscope for 63 hours. Since Fucci4 
probes were used in this imaging, the combinations of fluorescence color and each cell 
cycle phase are G1-red, S-blue, and G2/M-red and blue (the color is processed to white). 
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Figure 2-6. The length of each cell cycle phase in individual mouse PSCs. Each line of 
three graphs is showing distribution of length of G1, S, and G2/M phases. Most of 
mESCs and miPSCs have a very short G1 phase within 5 hours. On the other hands, a 
significant number of mEpiSCs have a prolonged G1 phase more than 5 hours. 
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Figure 2-7. Time-lapse imaging of hESCs using Fucci4 probes. Time-lapse imaging was 
performed with BZ-9000 for 71 hours. Since Fucci4 was used in this imaging, the 
combinations of fluorescence color and phases of cell cycle are G1-red, S-blue, G2/M -red 
and blue (the color of G2/M is processed to violet). 
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Figure 2-8. Time-lapse imaging of hiPSCs using Fucci4 probes. Time-lapse imaging was 
performed by FV1000-D for 63 hours. Since Fucci4 was used in this imaging, the 
combinations of fluorescence color and phases of cell cycle are G1-red, S-blue, G2/M-red 
and blue (the color of G2/M is processed to white). 
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Figure 2-9. The length of each cell cycle phase in individual human PSCs. Each line of 
three graphs is showing distribution of length of G1, S, and G2/M phase. The length of 
the G1 length of most hESCs and hiPSCs is 3-4 hours, but distributions of the G1 length 
were similar to mEpiSCs and a significant number of cells have a prolonged G1 phase 
more than 5 hours.  
  
50 
 
 
Figure 2-10. Time-lapse imaging of rESCs using Fucci4 probes. Time-lapse imaging was 
performed by FV1000-D for 63 hours. Since Fucci4 was used in this imaging, the 
combinations of fluorescence color and phases of cell cycle are G1-red, S-blue, G2/M-red 
and blue (the color of G2/M is processed to white). 
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Figure 2-11. Time-lapse imaging of riPSCs using Fucci4 probes. Time-lapse imaging 
was performed by FV1000-D for 63 hours. Since Fucci4 was used in this imaging, the 
combinations of fluorescence color and phases of cell cycle are G1-red, S-blue, G2/M-red 
and blue (the color of G2/M is processed to white). 
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Figure 2-12. The length of each cell cycle phase in individual rabbit PSCs. Each line of 
three graphs is showing distribution of length of G1, S, and G2/M phase. The length of 
the G1 length of most rESCs and riPSCs is 2-4 hours, but a significant number of cells 
have a prolonged G1 phase more than 5 hours.  
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(a) 
 
(b) 
 
Figure 2-13. Time-lapse imaging of hiPSCs using Fucci2 probes. (a) Time-lapse imaging 
was performed with an FV1000-D for 49 hours. Since Fucci2 was used in this imaging, 
the combinations of fluorescence color and phases of cell cycle are G1-red, S/G2/M-green, 
G1/S-red and green (the color of G1/S is processed to yellow). (b) The length of each cell 
cycle phase in individual hiPSCs. 
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Figure 2-14. Generating naïve-like hiPSCs. hiPSCs were transduced with the lentiviral 
vector expressing hOCT3/4-IRES-Venus. About one week after, Venus-positive cells 
were isolated and cultured about one week in primed PSCs medium. After colony 
formation, culture medium was replaced by naïve medium contained forskolin, and 
naïve PSCs-like colonies were picked up. 
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Figure 2-15. Time-lapse imaging of naïve-like riPSCs using Fucci4 probes. Time-lapse 
imaging was performed with FV1000-D for 63 hours. Since Fucci4 was used in this 
imaging, the combinations of fluorescence color and phases of cell cycle are G1-red, 
S-blue, G2/M-red and blue (the color of G2/M is processed to white). 
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Figure 2-16. Time-lapse imaging of naïve-like hiPSCs using Fucci4 probes. Time-lapse 
imaging was performed with FV1000-D for 80 hours. Since Fucci4 was used in this 
imaging, the combinations of fluorescence color and phases of cell cycle are G1-red, 
S-blue, G2/M-red and blue (the color of G2/M is processed to white). 
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Figure 2-17. The length of each cell cycle phase in individual naïve-like PSCs. Each line 
of three graphs is showing distribution of length of G1, S, and G2/M phase. The mean 
length of the G1 phase of naïve-like hiPSCs and naïve-like riPSCs is shorter than 
corresponding primed iPSCs, but cells with prolonged G1 phase longer than 5 hours are 
also observed.  
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Figure 2-18. Comparison of the G1 phase length in sequential cell division. X-axis shows 
sequential cell division of individual cells. Y-axis shows the length of each G1 phase.  
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Figure 2-19. Comparison of the length of the G1 phase and S/G2/M phases in individual 
cells. (a) Relationship between G1 phase and G2/M phases. (b) Relationship between G1 
phase and S phase.  
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(a)                                     (b) 
 
Figure 2-20. Spatio-ununiformity of cell cycle in the conoly. (a) hiPSCs. (b) mEpiSCs. 
Yellow circles show the position of hiPSCs that have a short G1 phase. White circles 
show the position of hiPSCs that have a prolonged G1 phase. 
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Figure 2-21. Definition of cell density. The cell density is defined as the number of cells 
within a circle with 20, 30, or 40 μm diameter from a selected cell in each time-lapse 
frame 
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Figure 2-22. The contour map of hiPSC colony. The contour maps show the number of 
cells within 20, 30, or 40 μm diameter from all selected cells. As compared with the 
original image, the cell density is measured correctively.  
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(a) 
 
(b) 
 
Figure 2-23. Correlation between the length of each cell cycle phase and the cell density. 
The cell density was calculated as an average of cell count during G1 or S/G2/M phases 
in each time-laps frame. (a) Correlation between the length of the G1 phase and the cell 
density. (b) Correlation between the length of the S/G2/M phases and the cell density. 
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Figure 2-24. Time-lapse imaging of HeLa cells using Fucci2 probes.  Time-lapse 
imaging was performed with an LCV110 for 132 hours. Since Fucci2 was used in this 
imaging, the combinations of fluorescence color and phases of cell cycle are G1- red, 
S/G2/M-green, G1/S-red and green (the color of G1/S is processed to yellow). 
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Figure 2-25. Time-lapse imaging of NMuMG cells using Fucci2 probes. Time-lapse 
imaging was performed with an LCV110 for 120 hours. Since Fucci2 was used in this 
imaging, the combinations of fluorescence color and phases of cell cycle are G1- red, 
S/G2/M-green, G1/S-red and green (the color of G1/S is processed to yellow). 
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(a)                               (b) 
 
(c)                                          (d) 
 
Figure 2-26. Correlation between the G1 phase length and the cell density.  (a)–(b) 
HeLa and NMuMG cells are affected by contact inhibition. The G1 phase length 
increased in direct proportion to the cell density (c) In case of iPS cells, if iPS cells were 
affected contact inhibition, length of G1 delay is at random, minimum delay is no delay, 
maximum delay is not beyond border which is in proportion to cell density. (d) Cell 
density of naïve PSCs cannot be measured for steric colony formation, but G1 phase 
dynamics of mESCs/iPSCs are predicted to ignore the cell density 
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 Modified Fagotto F et al. (2013) and Symonds CE et al. (2009) 
 
Figure 2-27. The mechanism of contact inhibition in differentiated somatic cells. (a) In 
differentiated somatic cells, when cells contacted other cells, proliferation signals are 
transmitted and the cell cycle is progressed by activation of cell cycle pathway. (b) 
Excessive proliferation signals arrest cells in G1 phase or enter cells in quiescent G0 
phase. 
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 Modified Fagotto F et al. (2013) and Symonds CE et al. (2009) 
 
Figure 2-28. Cell cycle mechanism of mESCs. Cell cycle progression of mESCs is 
stimulated by autocrine loop of proliferation signaling and does not require exogenous 
growth factors. 
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Figure 2-29. Correlation between the G1 phase length and the cell density. Naïve PSCs 
are not subject to contact inhibition. On the other hand, differentiated somatic cells are 
affected by contact inhibition, resulting in cell cycle arrest. In primed PSCs and 
probably naïve-like PSCs, the length of the G1 phase is affected by contact inhibition. 
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Figure 2-30. Novel feature of Naïve PSCs. The results in this study suggest that a short 
G1 phase that is not affected by the cell density can be a novel feature of naïve state.  
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Table 1. The mean length of the cell cycle stages in mouse, rabbit, and human PSCs. 
 
Cell types 
Length of the cell cycle stages (mean±SD) 
G1 phase (hour) S phase (hour) G2/M phase (hour) 
mESCs 2.41±0.79 5.67±1.27 3.60±1.31 
miPSCs 2.35±0.74 5.08±1.81 3.10±1.00 
mEpiSCs 3.03±1.45 4.96±1.36 3.23±1.12 
rESCs 3.02±0.75 5.84±1.65 4.09±2.14 
riPSCs 2.93±1.28 5.10±1.40 4.53±2.36 
Naïve-like riPSCs 3.26±0.81 6.77±0.82 3.41±1.30 
hESCs 3.50±1.09 6.48±1.10 4.24±1.54 
hiPSCs 4.31±1.85 7.22±2.10 4.75±2.50 
Naïve-like hiPSCs 3.31±1.29 6.34±1.03 3.85±1.56 
 
